Clinical trials
Phase 3 trials in Indonesia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
198 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 3 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 8 |
| 2006 | 9 |
| 2007 | 13 |
| 2008 | 9 |
| 2009 | 12 |
| 2010 | 5 |
| 2011 | 13 |
| 2012 | 11 |
| 2013 | 8 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 6 |
| 2018 | 9 |
| 2019 | 4 |
| 2020 | 13 |
| 2021 | 12 |
| 2022 | 7 |
| 2023 | 11 |
| 2024 | 13 |
| 2025 | 11 |
| 2026 | 7 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 137 |
| Unknown status | 30 |
| Recruiting | 10 |
| Terminated | 10 |
| Not yet recruiting | 5 |
| Withdrawn | 3 |
| Active, not recruiting | 3 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Indonesia University | 25 |
| Dexa Medica Group | 12 |
| AstraZeneca | 11 |
| Bayer | 10 |
| PT Bio Farma | 9 |
| Bristol-Myers Squibb | 6 |
| Hoffmann-La Roche | 6 |
| Fakultas Kedokteran Universitas Indonesia | 4 |
| Innogene Kalbiotech Pte. Ltd | 4 |
| Menzies School of Health Research | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 15 |
| Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Diabetes Mellitus, Type 2 | 7 |
| Tuberculosis | 6 |
| Cardiovascular Diseases | 4 |
| Dengue | 4 |
| Malaria, Vivax | 4 |
| Venous Thromboembolism | 4 |
| Acute Coronary Syndrome | 3 |
Trials
Showing 1 to 25 of 198. Each trial links to its page on Pharma Observatory.
98 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.